2.3.1.179	additional information	-	additional information	IC50 for platencin is 0.00195 ng/ml, IC50 for platensimycin is 0.00013 ng/ml	676903	
2.3.1.179	0.000048	-	platensimycin	from Streptomyces platensis, IC50: 48 nM, anti-bacterial effect is exerted through the selective targeting of beta-ketoacyl-[acyl-carrier-protein] synthase I/II, FabF/B, in the synthetic pathway of fatty acids, platensimycin interacts specifically with th	676148	
2.3.1.179	0.000097	-	dihydroplatensimycin	IC50: 97 nM	676148	
2.3.1.179	0.000113	-	platencin	exhibits a broad-spectrum Gram-positive antibacterial activity through inhibition of fatty acid biosynthesis, targets the two essential proteins, beta-ketoacyl-[acyl carrier protein] synthase II and III, i.e. FabF and FabH, FabF IC50: 113 nM, overview	676903	
2.3.1.179	0.00016	-	platensimycin	from Streptomyces platensis, IC50: 160 nM, anti-bacterial effect is exerted through the selective targeting of beta-ketoacyl-[acyl-carrier-protein] synthase I/II, FabF/B, in the synthetic pathway of fatty acids, platensimycin interacts specifically with t	676148	
2.3.1.179	0.00029	-	platensimycin	from a strain of Streptomyces platensis MA7339, specifically targets FabF, IC50: 290 nM, exhibits Gram-positive antibacterial activity	676903	
2.3.1.179	1.1	-	thiolactomycin	binding structure with mutant C163Q, IC50: 1.1 mM	676148